FDA Drug Application (020198) for ADALAT CC by ALVOGEN

Back to FDA Applications sponsored by ALVOGEN

Application Number020198
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage30MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB1 Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameADALAT CC
Active IngredientNIFEDIPINE

Active IngredientCount
List of drugs with Active Ingredient NIFEDIPINE6


Back to FDA Applications sponsored by ALVOGEN